feed,title,long_url,short_url
BioRxiv,The network of SARS-CoV-2-cancer molecular interactions and pathways,https://biorxiv.org/cgi/content/short/2022.04.04.487020v1?rss=1,https://bit.ly/3ubRvak
BioRxiv,Time series analysis of SARS-CoV-2 genomes and correlations among highly prevalent mutations,https://biorxiv.org/cgi/content/short/2022.04.05.487114v1?rss=1,https://bit.ly/3u9lSOO
BioRxiv,Evolution of Delta variant by non-Spike signature co-appearing mutations: trailblazer of COVID-19 disease outcome,https://biorxiv.org/cgi/content/short/2022.04.05.487103v1?rss=1,https://bit.ly/3j5NgqJ
BioRxiv,Targeted protein S-nitrosylation of ACE2 as potential treatment to prevent spread of SARS-CoV-2 infection,https://biorxiv.org/cgi/content/short/2022.04.05.487060v1?rss=1,https://bit.ly/3Jct8h9
BioRxiv,Screening of SARS-CoV-2 Antivirals Through a Cell-Based RNA-Dependent RNA Polymerase (RdRp) Reporter Assay,https://biorxiv.org/cgi/content/short/2022.04.04.486994v1?rss=1,https://bit.ly/3O1UQkq
